Genetic Disease Investigators, LLC has announced receipt of their second patent, U.S. Patent No. 10,238,673 B2, addressing dry eye treatment via a unique avenue—the autonomic nervous system. Inventor and president of Genetic Disease Investigators, Diana Driscoll, OD, explains how this was formulated. “This invention was born out of necessity for answers! I was a patient with dramatic autonomic dysfunction. One of the avenues of my research included normal tear production and how the autonomic nervous system affects basal or normal tear production, as well as the role of inflammation. Because I was personally affected, as were my children, we were motivated to get answers that have been missed by others.” Read more about the dry eye treatment in this feature from Women In Optometry. Read More.